A Multi-Omic and Ethical Framework for Newborn Screening in Wales
Wednesday, January 27, 2027 at 3:00 PM to 3:30 PM · 30 min. (Europe/London)
Women & Children's Health Stage
Day 1 - Wednesday 27th January
Multi-OmicsWomen & Children's Health
Information
The Wales Model: Orchestrating equity through a "one program, one laboratory" infrastructure.
Multi-Omics vs. Genomic Replacement: Utilizing metabolomics as the diagnostic mainstay while integrating genomics to finesse pathway specificity.
The Ethics of Screening: A critical analysis of the "more harm than good" principle, prioritizing individual infant benefit over aggregate data utility.
Technical Feasibility: Evaluating the use of dried blood spots for whole genome sequencing to build evidence for rare condition screening.